Taiwan
· Delayed Price · Currency is TWD Shine-On BioMedical Co.,Ltd. Statistics
Total Valuation
Shine-On BioMedical Co.,Ltd. has a market cap or net worth of TWD 3.33 billion. The enterprise value is 2.24 billion.
| Market Cap | 3.33B |
| Enterprise Value | 2.24B |
Important Dates
The next estimated earnings date is Friday, April 18, 2025.
| Earnings Date | Apr 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Shine-On BioMedical Co.,Ltd. has 49.80 million shares outstanding. The number of shares has increased by 2.03% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 49.80M |
| Shares Change (YoY) | +2.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.06% |
| Owned by Institutions (%) | n/a |
| Float | 23.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.05 |
| P/TBV Ratio | 3.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -31.59 |
| EV / Sales | 234.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -36.97 |
Financial Position
The company has a current ratio of 56.04, with a Debt / Equity ratio of 0.00.
| Current Ratio | 56.04 |
| Quick Ratio | 55.54 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.05 |
| Interest Coverage | -9,038.40 |
Financial Efficiency
Return on equity (ROE) is -6.29% and return on invested capital (ROIC) is -5.01%.
| Return on Equity (ROE) | -6.29% |
| Return on Assets (ROA) | -4.96% |
| Return on Capital (ROIC) | -5.01% |
| Revenue Per Employee | 501,263 |
| Profits Per Employee | -3.73M |
| Employee Count | 19 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.05% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +4.05% |
| 50-Day Moving Average | 66.45 |
| 200-Day Moving Average | 65.40 |
| Relative Strength Index (RSI) | 52.65 |
| Average Volume (20 Days) | 11,964 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shine-On BioMedical Co.,Ltd. had revenue of TWD 9.52 million and -70.83 million in losses. Loss per share was -1.42.
| Revenue | 9.52M |
| Gross Profit | 6.67M |
| Operating Income | -90.38M |
| Pretax Income | -69.73M |
| Net Income | -70.83M |
| EBITDA | -89.65M |
| EBIT | -90.38M |
| Loss Per Share | -1.42 |
Balance Sheet
The company has 1.09 billion in cash and 3.21 million in debt, giving a net cash position of 1.09 billion or 21.87 per share.
| Cash & Cash Equivalents | 1.09B |
| Total Debt | 3.21M |
| Net Cash | 1.09B |
| Net Cash Per Share | 21.87 |
| Equity (Book Value) | 1.09B |
| Book Value Per Share | 21.89 |
| Working Capital | 1.08B |
Cash Flow
In the last 12 months, operating cash flow was -60.48 million and capital expenditures -34,000, giving a free cash flow of -60.52 million.
| Operating Cash Flow | -60.48M |
| Capital Expenditures | -34,000 |
| Free Cash Flow | -60.52M |
| FCF Per Share | -1.22 |
Margins
| Gross Margin | 70.00% |
| Operating Margin | -949.01% |
| Pretax Margin | -732.18% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Shine-On BioMedical Co.,Ltd. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.03% |
| Shareholder Yield | -2.03% |
| Earnings Yield | -2.13% |
| FCF Yield | -1.82% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Shine-On BioMedical Co.,Ltd. has an Altman Z-Score of 89.8.
| Altman Z-Score | 89.8 |
| Piotroski F-Score | n/a |